Piper Brian 4/A
4/A · Aevi Genomic Medicine, Inc. · Filed May 16, 2018
Insider Transaction Report
Form 4/AAmended
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-08-11+110,000→ 110,000 totalExercise: $1.32Exp: 2027-08-11→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on August 11, 2018, then in 24 equal monthly installments on the 11th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.
- [F2]Reflects a reduction in the number of shares purchaseable under the stock option. A portion of the originally granted amount was void due to having exceeded certain plan limitations.